Back to Search
BRIAN CZERNIECKI, MD
MD
Surgery Physician
NPI: 1881620938IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
MD056377L(PA)
CMS Specialties
PrimaryGENERAL SURGERY
Education
RUTGERS R W JOHNSON MEDICAL SCHOOL (CAM/NEW BRUNS/PISC)
Class of 1988
Research & Publications (20)
Development of vaccines for high-risk ductal carcinoma in situ of the breast.
PMID 17638860·Cancer Res·2007
6-review
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.
PMID 17293384·Cancer Res·2007
3-trial
Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines.
PMID 11642602·Crit Rev Immunol·2001
6-review
Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology.
PMID 11330786·Semin Nucl Med·2001
6-review
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer.
PMID 19383888·Cancer Epidemiol Biomarkers Prev·2009
8-other
Ductal carcinoma in situ: state of the science and roadmap to advance the field.
PMID 19064970·J Clin Oncol·2009
6-review
Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists.
PMID 18802116·J Immunol·2008
4-observational
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
PMID 18098228·Cancer·2008
4-observational
Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
PMID 18176601·Oncogene·2008
6-review
Mammographic appearance of recurrent breast cancer after breast conservation therapy.
PMID 18206623·Acad Radiol·2008
8-other
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
PMID 18577706·Blood·2008
7-preclinical
Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer.
PMID 18621610·Clin Breast Cancer·2008
8-other
Biopsy findings after breast conservation therapy for early-stage invasive breast cancer.
PMID 17544594·Int J Radiat Oncol Biol Phys·2007
8-other
The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.
PMID 17631558·J Nucl Med·2007
8-other
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
PMID 17285396·Ann Surg Oncol·2007
8-other
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
PMID 17369575·J Clin Oncol·2007
4-observational
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
PMID 17440064·Cancer Res·2007
7-preclinical
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
PMID 16954551·J Nucl Med·2006
3-trial
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
PMID 17058288·Cancer·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 CIVIC CENTER BLVD
PHILADELPHIA, PA 19104 - Phone
- (215) 662-4392
Quick Facts
- NPI
- 1881620938
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile